Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Niagen Bioscience (NAGE) Net Cash Flow: 2011-2024

Historic Net Cash Flow for Niagen Bioscience (NAGE) over the last 12 years, with Dec 2024 value amounting to $17.3 million.

  • Niagen Bioscience's Net Cash Flow fell 15.44% to $3.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $31.9 million, marking a year-over-year increase of 466.97%. This contributed to the annual value of $17.3 million for FY2024, which is 151.82% up from last year.
  • Per Niagen Bioscience's latest filing, its Net Cash Flow stood at $17.3 million for FY2024, which was up 151.82% from $6.9 million recorded in FY2023.
  • Niagen Bioscience's 5-year Net Cash Flow high stood at $17.3 million for FY2024, and its period low was -$7.8 million during FY2022.
  • Its 3-year average for Net Cash Flow is $5.5 million, with a median of $6.9 million in 2023.
  • Its Net Cash Flow has fluctuated over the past 5 years, first surged by 644.78% in 2021, then tumbled by 167.51% in 2022.
  • Niagen Bioscience's Net Cash Flow (Yearly) stood at -$2.1 million in 2020, then surged by 644.78% to $11.5 million in 2021, then tumbled by 167.51% to -$7.8 million in 2022, then soared by 188.51% to $6.9 million in 2023, then skyrocketed by 151.82% to $17.3 million in 2024.